摘要
采用ELISA夹心法对食管癌患者手术前后血清可溶性白细胞介素2受体(sIL-2R)水平进行了动态观察,结果发现,有手术指征的食管瘤患者组血清sIL-2R水平(407±99u/ml)非常显著地高于正常对照组(265±88u/ml)(P<0.001),其中Ⅰ、Ⅲ组食管癌患者手术前后血清sIL-2R水平明显下降(Ⅰ组:术前;375±52u/ml术后:259±39u/ml;Ⅲ组:术前:383±73u/ml术后:260±64u/ml),而Ⅲ组病人手术前后血清sIL-2R水平无明显差异;部分术后追踪观察发现,复发者血清sIL-2R水平(959±143u/ml)与未复发者(345±78u/ml)有显著性差异(P<0.001).该研究结果说明血清sIL-2R水平在指导外科医生明确手术指征,选择手术方式、估计预后上有较为重要的参考价值。
Dynamic observation was made on the level of serum soluble interleukin 2 receptor(sIL2R) by ELISA method before and after operation on patients with operable esophageal carcinoma. Itwas found that serum sIL-2R of patients (407±99u/ml) was very stringly higher than that ofhealthy controls (265±88u/ml) (P<0. 001). These patients were divided into three groupsaccording to pathological severity. In Group Ⅰ and Ⅱ sIL-2R distinctly decreased after operation (Group Ⅰ:375 ±52u/ml pre-operation; 259±39u/ml post-operation;Group Ⅱ: 383±73u/ml pre operation;260±64u/ml post-operation), no distinct difference was found in Group Ⅲ. In some follow-ups, itwas discovered that the level of recurrent patients (959±143u/ml) was significantly higher than thatof un-recurrent ones (345±78u/ml) (P<0. 001). The results suggested that the serum sIL-2R levelmight provide surgeons with important reference in selecting operative ndication, operative method,and in anticipating prognosis.
出处
《泸州医学院学报》
1997年第2期101-103,共3页
Journal of Luzhou Medical College
关键词
食管肿瘤
围手术期
血清
SIL-2R
Esophageal carcinoma
operation
soluble interleukin 2 receptor